4893 items matching your search terms.

Is it time to abandon clinical breast examination?

Kiely, B. E. Goodwin, A.
MEDICAL JOURNAL OF AUSTRALIA, 2021     DOI:10.5694/mja2.51285

The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

King, M. T. Norman, R. Mercieca-Bebber, R. Costa, D. S. J. McTaggart-Cowan, H. Peacock, S. Janda, M. Muller, F. Viney, R. Pickard, A. S. Cella, D. Multi-Attribute Utility in Cancer, Consortium
VALUE IN HEALTH, 2021     DOI:10.1016/j.jval.2021.01.007

Incorporating circulating tumor DNA detection to radiographic assessment for treatment response in advanced EGFR-mutant lung cancer

Kok, P. S. Lee, K. Lord, S. John, T. Marschner, I. Wu, Y. L. Mok, T. S. K. Lee, C. K.
LUNG CANCER, 2021     DOI:10.1016/j.lungcan.2021.11.010

Clinical utility of plasma EGFR mutation detection with quantitative PCR in advanced lung cancer: A meta-analysis

Kok, P. S. Lee, K. Lord, S. Yang, J. C. Rosell, R. Goto, K. John, T. Wu, Y. L. Mok, T. S. K. Lee, C. K.
LUNG CANCER, 2021     DOI:10.1016/j.lungcan.2021.02.027

Tumor Response End Points as Surrogates for Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-Analysis

Kok, P. S. Yoon, W. H. Lord, S. Marschner, I. Friedlander, M. Lee, C. K.
JCO PRECIS ONCOL, 2021     DOI:10.1200/PO.21.00108

Barriers and potential solutions to international collaboration in neuro-oncology clinical trials: Challenges from the Australian perspective

Kong, B. Y. Carter, C. Nowak, A. K. Hovey, E. Lwin, Z. Haghighi, N. Gan, H. K. Sim, H. W. Ziegler, D. S. Barton, K. Parkinson, J. Leonard, R. Khasraw, M. Foote, M.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021     DOI:10.1111/ajco.13606

Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee

Kurtz, J. E. Gebski, V. Sukhin, V. Carey, M. Kong, I. Glasspool, R. M. Berek, J. S. de Paiva Batista, M. Hall, M. Kim, J. W. Yeoshoua, E. Fujiwara, N. Nam, B. H. Polleis, S. Lee, J. Y. Strojna, A. Farrelly, L. Schwameis, R. Fossati, R. Darlington, A. S. Lai, C. H. Wright, A. A. Rosenblat, O. Harter, P. Roxburgh, P. Chowdhury, R. R. Chang, T. C. Paoletti, X. Friedlander, M. Gynecologic Cancer InterGroup symptom benefit, committee
GYNECOLOGIC ONCOLOGY, 2021     DOI:10.1016/j.ygyno.2021.02.018

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

Lacas, B. Carmel, A. Landais, C. Wong, S. J. Licitra, L. Tobias, J. S. Burtness, B. Ghi, M. G. Cohen, E. E. W. Grau, C. Wolf, G. Hitt, R. Corvo, R. Budach, V. Kumar, S. Laskar, S. G. Mazeron, J. J. Zhong, L. P. Dobrowsky, W. Ghadjar, P. Fallai, C. Zakotnik, B. Sharma, A. Bensadoun, R. J. Ruo Redda, M. G. Racadot, S. Fountzilas, G. Brizel, D. Rovea, P. Argiris, A. Nagy, Z. T. Lee, J. W. Fortpied, C. Harris, J. Bourhis, J. Auperin, A. Blanchard, P. Pignon, J. P. Mach-Nc Collaborative Group
RADIOTHERAPY AND ONCOLOGY, 2021     DOI:10.1016/j.radonc.2021.01.013

Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK

Lau, D. K. Luk, I. Y. Jenkins, L. J. Martin, A. Williams, D. S. Schoffer, K. L. Chionh, F. Buchert, M. Sjoquist, K. Boussioutas, A. Hayes, S. A. Ernst, M. Weickhardt, A. J. Pavlakis, N. Tebbutt, N. C. Mariadason, J. M.
MOLECULAR CANCER THERAPEUTICS, 2021     DOI:10.1158/1535-7163.MCT-20-0836

Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK

Lau, D. K. Luk, I. Y. Jenkins, L. J. Martin, A. Williams, D. S. Schoffer, K. L. Chionh, F. Buchert, M. Sjoquist, K. Boussioutas, A. Hayes, S. A. Ernst, M. Weickhardt, A. J. Pavlakis, N. Tebbutt, N. C. Mariadason, J. M.
MOLECULAR CANCER THERAPEUTICS, 2021     DOI:10.1158/1535-7163.MCT-20-0836

Higher versus Lower Oxygen Concentration during Respiratory Support in the Delivery Room in Extremely Preterm Infants: A Pilot Feasibility Study

Law, B. H. Y. Asztalos, E. Finer, N. N. Yaskina, M. Vento, M. Tarnow-Mordi, W. Shah, P. S. Schmolzer, G. M.
CHILDREN (BASEL), 2021     DOI:10.3390/children8110942

Return to work following laparoscopic-assisted resection or open resection for rectal cancer: Findings from AlaCaRT-Australasian Laparoscopic Cancer of the Rectum Trial

Law, C. K. Brewer, K. Brown, C. Wilson, K. Bailey, L. Hague, W. Simes, J. R. Stevenson, A. Solomon, M. Morton, R. L. Australasian Gastro-Intestinal Trials Group, ALaCaRT investigators
CANCER MED, 2021     DOI:10.1002/cam4.3623

Healthcare Costs of Laparoscopic versus Open Surgery for Rectal Cancer Patients in the First 12 Months: A Secondary Endpoint Analysis of the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT)

Law, C. K. Stevenson, A. R. L. Solomon, M. Hague, W. Wilson, K. Simes, J. R. Morton, R. L. Australasian Gastro-Intestinal Trials Group, ALaCaRT Investigators
ANNALS OF SURGICAL ONCOLOGY, 2021     DOI:10.1245/s10434-021-10902-5

An exploration of factors associated with food protein-induced enterocolitis syndrome: Birth, infant feeding and food triggers

Lee, E. Barnes, E. H. Mehr, S. Campbell, D. E.
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2021     DOI:10.1111/pai.13448

Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia

Lee, J. Y. Marian, O. C. Don, A. S.
NEUROMOLECULAR MEDICINE, 2021     DOI:10.1007/s12017-021-08644-4